{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:17:15Z","timestamp":1785428235331,"version":"3.56.0"},"reference-count":23,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Norfolk and Norwich University Hospital"},{"id":[{"id":"https:\/\/ror.org\/021zm6p18","id-type":"ROR","asserted-by":"publisher"}]},{"name":"B. Braun"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Percutaneous coronary intervention (PCI) using drug-coated balloons (DCBs) may provide outcomes comparable to drug-eluting stents (DESs) due to the absence of a permanent implant and improved coronary artery remodelling. This study compared clinical outcomes of DCB-only angioplasty with DESs in a real-world setting. All patients undergoing PCI with DCBs or DESs for de novo disease were included in a propensity score-matched analysis using prospective and retrospective collected data from a single centre. The primary outcome was target lesion revascularisation (TLR) at 12 months. The secondary outcomes were major adverse cardiac events (MACEs) defined as a composite of all-cause death, myocardial infarction, or TLR at 12 months. Propensity matching produced 904 DCB lesions (719 patients) matched to 1424 DES lesions (1271 patients). The DCB group had smaller coronary arteries, shorter treated segments, and more bifurcation lesions. The mean age was 65 years, 22% of patients had prior MI, 16% had diabetes, and 58% had acute coronary syndromes. The rate of TLR at 12 months was as follows: 2.3% with DCBs; 2.5% with DESs (OR 0.86, p = 0.726, 95% CI 0.37\u20132.02). MACE was 8.2% with DCBs and 7.3% for DESs (OR 1.04, 95% CI 0.73\u20131.47). Results suggest comparable outcomes in patients who received paclitaxel DCBs compared to DESs without excess MACE, highlighting the need for randomised controlled trials.<\/jats:p>","DOI":"10.3390\/jcdd13070327","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:55:21Z","timestamp":1783990521000},"page":"327","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Paclitaxel-Coated Balloon Angioplasty vs. Drug-Eluting Stents in the Management of Acute and Chronic Coronary Syndromes in All Vessel Sizes: A Propensity-Matched Study (The OUTDES Study)"],"prefix":"10.3390","volume":"13","author":[{"given":"Upul","family":"Wickramarachchi","sequence":"first","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Corballis","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3549-8761","authenticated-orcid":false,"given":"Alisdair","family":"Ryding","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-3345","authenticated-orcid":false,"given":"Toomas","family":"Sarev","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Wistow","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Flather","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-2389","authenticated-orcid":false,"given":"Simon","family":"Eccleshall","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease","volume":"331","author":"Fischman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease","volume":"375","author":"Mannsverk","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0021-9150(01)00618-9","article-title":"Treating Atherosclerosis: Local Drug Delivery from Laboratory Studies to Clinical Trials","volume":"160","author":"Gershlick","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local Paclitaxel Induces Late Lumen Enlargement in Coronary Arteries after Balloon Angioplasty","volume":"104","author":"Kleber","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.jcin.2015.08.029","article-title":"Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left with a Dissection","volume":"8","author":"Cortese","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS Guidelines on Myocardial Revascularization","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-Coated Balloons for Small Coronary Artery Disease (BASKET-SMALL 2): An Open-Label Randomised Non-Inferiority Trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00392-015-0957-6","article-title":"Drug Eluting Balloons as Stand Alone Procedure for Coronary Bifurcational Lesions: Results of the Randomized Multicenter PEPCAD-BIF Trial","volume":"105","author":"Kleber","year":"2016","journal-title":"Clin. Res. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/joic.12301","article-title":"Results from the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated without Stents?","volume":"29","author":"Bruch","year":"2016","journal-title":"J. Interv. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-Coated Balloon for Treatment of De-Novo Coronary Artery Lesions in Patients with High Bleeding Risk (DEBUT): A Single-Blind, Randomised, Non-Inferiority Trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare Metal or Drug-Eluting Stent versus Drug-Coated Balloon in Non-ST-Elevation Myocardial Infarction: The Randomised PEPCAD NSTEMI Trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-Coated Balloon Angioplasty versus Drug-Eluting Stent in Acute Myocardial Infarction","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document","volume":"137","author":"McFadden","year":"2018","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third Universal Definition of Myocardial Infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/aje\/kwq224","article-title":"Statistical Criteria for Selecting the Optimal Number of Untreated Subjects Matched to Each Treated Subject When Using Many-To-One Matching on the Propensity Score","volume":"172","author":"Austin","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon with a Paclitaxel-Eluting Stent in Small Coronary Vessels: The BELLO (Balloon Elution and Late Loss Optimization) Study","volume":"60","author":"Latib","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10557-021-07172-4","article-title":"A Non-Inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary de Novo Lesions","volume":"36","author":"Yu","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_19","first-page":"E317","article-title":"Long-Term Efficacy of Drug Coated Balloons Compared with New Generation Drug-Eluting Stents for the Treatment of de Novo Coronary Artery Lesions","volume":"92","author":"Venetsanos","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0140-6736(24)01594-0","article-title":"Drug-Coated Balloon Angioplasty with Rescue Stenting versus Intended Stenting for the Treatment of Patients with de Novo Coronary Artery Lesions (REC-CAGEFREE I): An Open-Label, Randomised, Non-Inferiority Trial","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3270132","DOI":"10.1155\/2019\/3270132","article-title":"The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era","volume":"2019","author":"Zheng","year":"2019","journal-title":"J. Interv. Cardiol."},{"key":"ref_22","first-page":"E35","article-title":"Optical Coherence Tomography Analysis of Late Lumen Enlargement after Paclitaxel-Coated Balloon Angioplasty for De-Novo Coronary Artery Disease","volume":"98","author":"Sogabe","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3349\/ymj.2016.57.3.606","article-title":"Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of de Novo Coronary Lesions of Main Vessels","volume":"57","author":"Her","year":"2016","journal-title":"Yonsei Med. J."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/7\/327\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:15:29Z","timestamp":1784261729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/7\/327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcdd13070327"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13070327","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}